Pre-vaccination IgG screening for mumps is the most cost-effectiveness immunization strategy among Health Care Workers
Authors:
- 20 March 2019
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 15 (5) , 1135-1138
Abstract
Health Care Workers (HCWs) have an increased risk of contracting contagious disease, including mumps. In January 2017 the Italian National Vaccine Prevention Plan 2017–2019, recommended the administration of a dose of MMR vaccine (Measles-Mumps-Rubella) to the Health Care Workers (HCWs) that, working in a risky environment, did not carry out the complete vaccination cycle of MMR or that are seronegative for at least one of the three vaccine viruses. In October of the same year, the Advisory Committee on Immunization Practices (ACIP) recommended a third dose of a vaccine containing Mumps Virus for people previously vaccinated with 2 doses, belonging to a group or to a population at increased risk of acquire mumps in the event of an epidemic. We analyzed the clinical records and values of mumps-specific IgG antibodies of 3032 HCWs (mean age 32.80 ± 10.75 years), that underwent occupational health surveillance between January 1st 2017 and March 31th 2018. The HCWs were also screened for measles, rubella, mumps using serological methods. 13% (405) was seronegative for mumps, especially among HCWs between 18 and 36 years. We calculated the cost-effectiveness of two-doses and three-doses MMR vaccination. The cost of vaccination without screening was significantly more expensive (cost difference: 99 712 € and 184 996 €) both in case of two-dose and three-dose MMR vaccination respectively. Our study suggests that, in HCWs, the assessment of the mumps antibody titer before vaccination may be a useful complement to vaccination itself, because it is more accurate and cost-effective than direct immunization of unvaccinated subjects.Keywords
This publication has 21 references indexed in Scilit:
- Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak ControlNew England Journal of Medicine, 2017
- Low vaccination coverage among italian healthcare workers in 2013Human Vaccines & Immunotherapeutics, 2014
- Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011Human Vaccines & Immunotherapeutics, 2014
- Comparison of automated chemiluminescence immunoassays with capture enzyme immunoassays for the detection of measles and mumps IgM antibodies in serumJournal of Virological Methods, 2014
- Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011Human Vaccines & Immunotherapeutics, 2013
- Seropositivity Rates for Measles, Mumps, and Rubella IgG and Costs Associated with Testing and RevaccinationClinical and Vaccine Immunology, 2013
- Waning Antibody Levels and Avidity: Implications for MMR Vaccine-Induced ProtectionThe Journal of Infectious Diseases, 2012
- Seroepidemiology of mumps in Europe (1996–2008): why do outbreaks occur in highly vaccinated populations?Epidemiology and Infection, 2012
- Vaccination in healthcare workers: an Italian perspectiveExpert Review of Vaccines, 2010
- An audit of vaccination coverage among vaccination service workers in Puglia, ItalyAmerican Journal of Infection Control, 2009